Viewing Study NCT01455259


Ignite Creation Date: 2025-12-24 @ 3:06 PM
Ignite Modification Date: 2025-12-26 @ 4:14 PM
Study NCT ID: NCT01455259
Status: COMPLETED
Last Update Posted: 2016-02-17
First Post: 2011-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/IIa AdCD40L Immunogene Therapy for Malignant Melanoma and Other Solid Tumors
Sponsor: Uppsala University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module